These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8914238)

  • 1. Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients.
    de Maar EF; Kleibeuker JH; Boersma-van Ek W; The TH; van Son WJ
    Transpl Int; 1996; 9(6):576-80. PubMed ID: 8914238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome.
    Watcharananan SP; Louhapanswat S; Chantratita W; Jirasiritham S; Sumethkul V
    Transplant Proc; 2012 Apr; 44(3):701-5. PubMed ID: 22483472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
    Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
    Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
    Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
    Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.
    Jorgenson MR; Descourouez JL; Cardinale B; Lyu B; Astor BC; Garg N; Saddler CM; Smith JA; Mandelbrot DA
    Transpl Infect Dis; 2019 Jun; 21(3):e13080. PubMed ID: 30891915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
    Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
    Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
    Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ulcers during the course of cytomegalovirus infection in renal transplant recipients.
    López-Pintor RM; Hernández G; de Arriba L; Morales JM; Jiménez C; de Andrés A
    Transplant Proc; 2009; 41(6):2419-21. PubMed ID: 19715938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients.
    Benedetti E; Mihalov M; Asolati M; Kirby J; Dunn T; Raofi V; Fontaine M; Pollak R
    Clin Transplant; 1998 Oct; 12(5):391-5. PubMed ID: 9787946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients.
    van den Berg AP; van der Bij W; van Son WJ; Anema J; van der Giessen M; Schirm J; Tegzess AM; The TH
    Transplantation; 1989 Dec; 48(6):991-5. PubMed ID: 2556817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive therapy for the prevention of cytomegalovirus disease in renal transplant recipients: our preliminary experience.
    Paudice N; Mehmetaj A; Zanazzi M; Moscarelli L; Piperno R; Di Maria L; Bertoni E; Salvadori M
    Transplant Proc; 2009 May; 41(4):1204-6. PubMed ID: 19460517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients.
    Nafar M; Roshan A; Pour-Reza-Gholi F; Samadian F; Ahmadpoor P; Samavat S; Abbasi MA
    Iran J Kidney Dis; 2014 May; 8(3):231-5. PubMed ID: 24878947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
    Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
    Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.